Literature DB >> 2267681

Adrenocortical function in patients with pulmonary tuberculosis.

G R Sarma1, C Immanuel, G Ramachandran, P V Krishnamurthy, V Kumaraswami, R Prabhakar.   

Abstract

Adrenocortical function was studied in patients with pulmonary tuberculosis and the findings compared with those in healthy subjects. Plasma cortisol levels in newly diagnosed patients were appreciably higher than in the healthy subjects (P less than 0.001). A normal (positive) response to ACTH (tetracosactrin) stimulation was observed in 35 (97%) of 36 healthy subjects, 15 (56%) of 27 newly diagnosed patients with tuberculosis and 5 (42%) of 12 chronic cases (i.e. those who had had the disease for more than 3 years); the difference between the healthy subjects and the two groups of tuberculosis patients was highly significant (P less than 0.001). Dexamethasone caused an appreciable decrease in the plasma cortisol levels of tuberculosis patients. Considering the diurnal variation of cortisol secretion, there was a steady decline in the cortisol levels between 08:00 and 20:00 in the healthy subjects (P = 0.02); in the tuberculosis patients, however, there was a decrease up to 16:00 followed by a significant increase (P = 0.05), and the mean value at 20:00 was similar to that at 08:00.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2267681     DOI: 10.1016/0041-3879(90)90041-6

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  10 in total

Review 1.  The endocrinology of adrenal tuberculosis: the effects of tuberculosis on the hypothalamo-pituitary-adrenal axis and adrenocortical function.

Authors:  F Kelestimur
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

2.  Low dose (1 microg) adrenocorticotropin stimulation test in the evaluation of hypothalamo-pituitary-adrenal axis in patients with active pulmonary tuberculosis.

Authors:  F Keleştimur; Z Göktaş; I Gülmez; K Unlühizarci; F Bayram; M Ozesmi; M Güven; A Tutuş
Journal:  J Endocrinol Invest       Date:  2000-04       Impact factor: 4.256

3.  ADRENAL HISTOPLASMOSIS: AN EASTERN INDIAN PERSPECTIVE.

Authors:  S S Agrawal; P P Chakraborty; A Sinha; A Maiti; M Chakraborty
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

4.  Clinical Profile of Addison's Disease in a Tertiary Care Institute, Southern India - The Changing Landscape.

Authors:  Subbiah Sridhar; Karthik Balachandran; Roshan Nazirudeen; Vasanthiy Natarajan; Jayaraman Sangumani
Journal:  Indian J Endocrinol Metab       Date:  2022-04-27

Review 5.  Rheumatoid arthritis: how well do the theories fit the evidence?

Authors:  J McCulloch; P M Lydyard; G A Rook
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

Review 6.  Avoidance and management of adverse reactions to antituberculosis drugs.

Authors:  A M Patel; J McKeon
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

7.  Prevalence, distribution and functional significance of the -237C to T polymorphism in the IL-12Rβ2 promoter in Indian tuberculosis patients.

Authors:  Vikas Kumar Verma; Vibha Taneja; Anand Jaiswal; Sangeeta Sharma; Digamber Behera; Vishnubhatla Sreenivas; Shyam Singh Chauhan; Hanumanthappa Krishna Prasad
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

8.  Sub-clinical addison's disease.

Authors:  Manash P Baruah
Journal:  Indian J Endocrinol Metab       Date:  2012-12

9.  Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test.

Authors:  René Rodríguez-Gutiérrez; Adrian Rendon; Maximiliano Barrera-Sánchez; Kevin Erick Gabriel Carlos-Reyna; Neri Alejandro Álvarez-Villalobos; Gloria González-Saldivar; José Gerardo González-González
Journal:  Int J Endocrinol       Date:  2016-02-23       Impact factor: 3.257

Review 10.  For Whom the Clock Ticks: Clinical Chronobiology for Infectious Diseases.

Authors:  Aïssatou Bailo Diallo; Benjamin Coiffard; Marc Leone; Soraya Mezouar; Jean-Louis Mege
Journal:  Front Immunol       Date:  2020-07-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.